Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...

Gore & Associates: Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold: 6–10: 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) ...

Cook Medical. P.O. Box 489, Bloomington, IN 47402 . PHONE: (800) 457-4500 | FAX: (800) 554-8335 ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...